Recent clinical data further support this effect: perindopril therapy in essential hypertensive patients was shown to reduce adrenaline-induced platelet aggregation over one month of treatment, suggesting ACE inhibitors can enhance NO-mediated anti-aggregatory function in vivo. The gene discussed is ACE; the disease is hypertensive disorder.